Introduction
============

Obesity is reaching epidemic proportions in developed countries. As bariatric surgery is effective in inducing weight loss and reducing comorbidities associated with obesity, it is being increasingly used in several countries.[@ref1] A concern is that bariatric surgery may adversely affect bone health by increasing bone resorption markers,[@ref2] [@ref3] [@ref4] reducing bone mineral density,[@ref5] and altering bone histomorphometry parameters.[@ref6] [@ref7] [@ref8] Despite this, only three studies have looked at its effect on risk of fracture and results are contradictory.[@ref9] [@ref10] [@ref11] Moreover, the baseline risk of fracture in severely obese patients undergoing bariatric surgery has not been determined, the effect of bariatric surgery on fracture sites has not been established owing to insufficient study power, and whether fracture risk differs by type of bariatric procedure remains unclear. Therefore, larger studies exploring the risk of fracture before and after bariatric surgery are needed. This question is very important, as it may lead to a change in the preoperative and postoperative management of these patients. It may also stimulate the development of preventive and therapeutic strategies to minimize the effect of this procedure on bone.

This study aimed to evaluate the effect of obesity and bariatric procedures on risk and sites of fracture in severely obese patients who underwent bariatric surgery compared with age and sex matched obese and non-obese controls. We hypothesized that severely obese patients undergoing bariatric surgery would be at increased risk of fracture before surgery owing to their higher degree of obesity, which could predispose to falls as well as to diseases (such as type 2 diabetes) and abnormalities in mineral metabolism (such as vitamin D deficiency and secondary hyperparathyroidism) that are associated with impaired bone health[@ref12] [@ref13] [@ref14] [@ref15]; that fracture risk would be higher after surgery owing to altered bone metabolism resulting from weight loss and from anatomical changes induced by surgery (such as nutrient deficiencies)[@ref2] [@ref3] [@ref16] [@ref17] [@ref18]; that fracture sites would change after surgery, favoring cortical sites owing to the high prevalence of secondary hyperparathyroidism after surgery and also the hip owing to the massive weight loss induced by bariatric surgery[@ref19] [@ref20] [@ref21]; and that bariatric procedures that include a malabsorptive component would have a more unfavorable effect on fracture risk than purely restrictive procedures, owing to their higher risk of inducing deficiencies in nutrients that are important for bone health.[@ref22] [@ref23]

Methods
=======

Study design and data sources
-----------------------------

We did a retrospective, nested case-control study in the province of Quebec, Canada, between 2001 and 2014, using administrative databases from the Quebec Integrated Chronic Diseases Surveillance System (QICDSS).[@ref24] The QICDSS links five population based healthcare administrative databases that contain information related to the management of the public health insurance programs covering the health services offered to all residents. The QICDSS contains information on 95.3% of the Quebec population,[@ref24] and its creation has been approved by the government agencies with legal management of these databases, the Research Ethics Board of public health, and the Commission d\'accès à l\'information.

For this study, we used the health insurance registry (FIPA), hospital discharges (Med-Echo), and physician billing claims (PCD) databases. FIPA contains demographic information as well as data about the eligibility and admissibility of individuals to health insurance programs. Med-Echo includes information related to hospital admissions (date of admission, length of stay, diagnoses and comorbidities at admission, all hospital care provided, destination at discharge). Diagnoses are coded using 16 diagnostic codes from ICD-9-CM (international classification of diseases, ninth revision, clinical modification) before 1 April 2006 and 26 diagnostic codes from ICD-10-CA (international classification of diseases, 10th revision, Canada) thereafter. Therapeutic interventions were recorded using the Canadian Classification of Diagnostic, Therapeutic, and Surgical procedures (CCP with ICD-9-CM) and the Canadian Classification of Interventions (CCI with ICD-10-CM). Finally, PCD contains information related to physicians' reimbursement (medical service billing codes for the clinical services, dates and locations of the clinical services provided, and ICD-9-CM diagnosis codes).

Identification of cohorts
-------------------------

We combined diagnostic, therapeutic, and medical service billing codes to construct three groups: a group of severely obese patients who had undergone bariatric surgery (bariatric group), a control group of obese people who did not undergo bariatric surgery (obese group), and a control group of non-obese people (non-obese group). To be in the bariatric group, patients had to have a medical service billing code (PCD) associated with any bariatric surgery accompanied by a diagnostic code of obesity, a hospital admission (Med-Echo) within 30 days of the billing code with a primary or secondary diagnostic code of obesity, and an intervention code from the CCP/CCI associated with bariatric surgery during the hospital admission. We defined the index date as the date of the medical service billing code related to the surgery (see appendix 1 for codes). We paired the cohort of bariatric patients in a one to three ratio with obese people and in a one to 10 ratio with non-obese people of the same age (±3 years) and sex. The following conditions were required for people to be in the obese group: at least three medical service claims associated with a diagnostic code of obesity on different dates but within two years; at least one of these claims had to appear within six months of the index date of their bariatric counterpart; no claim or intervention code related to bariatric surgery. To be in the non-obese group, no record of any medical service claim or hospital admission mentioning a diagnosis of obesity or bariatric surgery had to be found. Detailed information related to the type of bariatric surgery was available only after implementation of ICD-10-CA coding in the hospital discharge database in 2006. We used CCI intervention codes to define four types of bariatric surgeries: adjustable gastric banding (1.NF.78.XP, 1.NF.78.EJ, 1.NF.78.XO), sleeve gastrectomy (1.NF.78.WJ, 1.NF.78.GB), Roux-en-Y gastric bypass (1.NF.78.SH, 1.NF.78.DQ), and biliopancreatic diversion (1.NF.78.SJ, 1.NF.78.DO, 1.NF.78.SI, 1.NF.78.DI) (see appendix 1 for details).

Fracture outcomes
-----------------

The primary endpoint was the occurrence of a fracture. To identify fracture events and sites, we used a previously developed and validated algorithm that uses PCD.[@ref16] The algorithm was designed to first select all medical service billing codes potentially associated with fracture treatment: claims with medical service billing codes definitively related to fracture care (that is, open or closed reduction) or claims with medical service billing codes not limited to fracture care (that is, immobilization, consultation, principal or follow-up visit with an orthopedic surgeon, emergency physician, or general practitioner) if they were combined with ICD-9-CM diagnostic codes of fracture. The algorithm considered an incident fracture to have occurred if there was at least one claim associated with fracture treatment (open reduction, closed reduction, immobilization), principal visit to an orthopedic surgeon with at least one other claim, or consultation with an orthopedic surgeon with at least one other claim. We referred to the claim allowing identification of fracture as the ''index claim."

We defined fracture sites by the specific medical service code of the index claim related to the treatment of fracture or, if not specific to the treatment of fracture, to the ICD-9-CM code. To establish the complete temporal sequence of medical care for each fracture, the algorithm identified any other claim (emergency room visit, follow-up visit) related to the same anatomical site. The date of the fracture corresponded to the date of the first claim in the temporal sequence of medical care. Finally, we established a six month period as the ''washout period'' between two clinical sequences related to the same anatomical fracture to minimize potential misclassification of fracture follow-up as a new incident fracture. The validity of this algorithm has been evaluated and published.[@ref20] Briefly, a sensitivity and positive predictive value of at least 80% have been shown for non-vertebral fractures. Craniofacial, hand, finger, and toe fractures were excluded.

Confounding factors associated with fracture risk
-------------------------------------------------

We assessed several potential confounding factors, including material and social deprivation,[@ref25] area of residence, fracture history, and number of comorbidities. We divided information on the area of residence into subsets (urban versus rural)[@ref25] and noted fracture history before surgery (yes/no). Finally, we used a coding algorithm developed by Quan et al to define 30 relevant Elixhauser comorbidities in administrative databases: namely, AIDS/HIV, alcohol abuse, anemia, cardiac arrhythmia, rheumatoid arthritis, coagulopathy, chronic pulmonary disease, dementia, depression, complicated and uncomplicated diabetes, drug abuse, fluid and electrolyte disorders, heart failure, complicated and uncomplicated hypertension, liver disease, lymphoma, metastatic cancer, other neurological disorders, osteoporosis, paralysis, pulmonary circulation disorders, psychoses, renal failure, hypothyroidism, solid tumor, peptic ulcer disease, valvular disease, peripheral vascular disease, and weight loss.[@ref26] We selected the model adjusted for the number of comorbidities over a model that adjusted for the most prevalent and relevant comorbidities included individually (cardiovascular disease, hypertension, chronic pulmonary disease, diabetes, cancer), as it was significantly better (more appropriate according to fitting criterion; that is, lower quasi-likelihood information criterion) and more parsimonious. We considered people to have the comorbidity if there was one hospital admission or two physician claims, at least 30 days apart, recorded in the five years before the index date, excluding the 30 days before the index date.[@ref27]

Statistical analyses
--------------------

We used SAS Enterprise Guide, version 6.1, for analyses. We compared descriptive characteristics of the groups by using the χ^2^ test for age and sex and univariate conditional multinomial regression for other characteristics. To evaluate changes in fracture risk and pattern before and after the index date, we used crude and adjusted conditional Poisson regression models to estimate relative risks and their 95% confidence intervals. This regression method took into account paired data and included a stratum indicator variable that considers that matched individuals come from the same cluster*.* As loss to follow-up and deaths were very low after the index date and similar between groups, censure rates were very low and did not affect the results. We preferred Poisson regression models over survival models, as they consider all fractures sustained by an individual during each period. Within each group, we compared fracture rates before and after the index date by using adjusted Poisson regression models for clustered data. The observations were not completely independent in this analysis, as the same individuals were compared before and after their index date (repeated measures).

As time to first fracture is also important after bariatric surgery to evaluate whether fracture risk was growing more rapidly in the bariatric group than in the control groups, we used life table methods to compare survival curves and hazard functions between groups for the period after bariatric surgery (or the index date). In this analysis, we analyzed the time between the index date and the first of the following events: time to first fracture (event of interest), death (censored), loss to follow-up (censored), and end of study (censored). Survival curves and hazard functions were not adjusted for potential confounding factors. Lastly, we did a subgroup analysis on fracture risk by type of bariatric surgery in patients who had undergone bariatric surgery since 2006. As results were similar when we analyzed sexes separately, only data for the entire group are presented.

Patient involvement
-------------------

No patients were involved in setting the research question or the outcome measures, nor were they involved in developing plans for design of the study. No patients were asked to advise on interpretation or writing up of results. There are no plans to disseminate the results of the research to study participants or the relevant patient community.

Results
=======

Baseline characteristics of groups
----------------------------------

Between 1 April 2001 and 31 March 2014, we identified 12 676 severely obese people who had undergone bariatric surgery; 9169 (72.3%) were women, and the mean age was 42.6 (SD 11.1) years (table 1[](#tbl1){ref-type="table"}). The obese and non-obese groups were composed of 38 028 and 126 760 age and sex matched people, respectively. Bariatric patients were more likely to come from small cities and rural areas, to be materially and socially disadvantaged, and to have a history of fracture compared with people in both control groups. Moreover, the proportion of patients with three or more comorbidities in the five years before their index date was higher in the bariatric group than in the control groups. People in the bariatric group were more likely to have cardiovascular disease, hypertension, chronic pulmonary disease, diabetes, hypothyroidism, renal failure, and depression but less likely to be diagnosed as having osteoporosis.

###### 

Baseline characteristics of groups. Values are numbers (percentages) unless stated otherwise

  Characteristics                                                        Bariatric (n=12 676)   Obese (n=38 028)   Non-obese (n=126 760)   P value\*
  ---------------------------------------------------------------------- ---------------------- ------------------ ----------------------- -----------
  Women                                                                  9169 (72.3)            27 507 (72.3)      91 680 (72.3)           1.00
  Mean (SD) age, years                                                   42.6 (11)              42.7 (11)          42.6 (11)               0.22
  Area of residence:                                                                                                                       
   Montreal census metropolitan area                                     4653 (36.7)            20 647 (54.3)      59 363 (46.8)           \<0.001
   Other census metropolitan area (≥100 000 inhabitants)                 2556 (20.2)            8697 (22.9)        25 672 (20.3)           
   Census agglomeration areas (between 10 000 and 100 000 inhabitants)   2472 (19.5)            3557 (9.4)         15 063 (11.9)           
   Small towns and rural areas                                           2926 (23.1)            4994 (13.1)        25 527 (20.1)           
   Missing                                                               69 (0.5)               133 (0.3)          1135 (0.9)              
  Fifth of material deprivation†:                                                                                                          
   1 (more privileged)                                                   1566 (12.4)            7562 (19.9)        25 473 (20.1)           \<0.001
   2                                                                     2308 (18.2)            8209 (21.6)        25 417 (20.1)           
   3                                                                     2578 (20.3)            7867 (20.7)        24 402 (19.3)           
   4                                                                     2839 (22.4)            7265 (19.1)        23 883 (18.8)           
   5 (more disadvantaged)                                                2920 (23.0)            5937 (15.6)        22 570 (17.8)           
   Missing                                                               465 (3.7)              1188 (3.1)         5015 (4.0)              
  Fifth of social deprivation†:                                                                                                            
   1 (more privileged)                                                   2362 (18.6)            7809 (20.5)        25 342 (20.0)           \<0.001
   2                                                                     2408 (19.0)            7483 (19.7)        25 369 (20.0)           
   3                                                                     2548 (20.1)            7444 (19.6)        24 580 (19.4)           
   4                                                                     2408 (19.0)            7337 (19.3)        23 614 (18.6)           
   5 (more disadvantaged)                                                2485 (19.6)            6767 (17.8)        22 840 (18.0)           
   Missing                                                               465 (3.7)              1188 (3.1)         5015 (4.0)              
  History of fracture (before index date)                                1326 (10.5)            3065 (8.1)         8329 (6.6)              \<0.001
  No of comorbidities‡:                                                                                                                    
   None                                                                  3886 (30.7)            20 549 (54.0)      86 039 (67.9)           \<0.001
   1-2                                                                   6949 (54.8)            15 455 (40.6)      37 785 (29.8)           
   ≥3                                                                    1841 (14.5)            2024 (5.3)         2936 (2.3)              
  Type of comorbidities (most prevalent)‡:                                                                                                 
   Cardiovascular disease§                                               873 (6.9)              1389 (3.7)         2921 (2.3)              \<0.001
   Hypertension                                                          3757 (29.6)            5798 (15.2)        9411 (7.4)              \<0.001
   Chronic pulmonary disease                                             2452 (19.3)            4136 (10.9)        7867 (6.2)              \<0.001
   Diabetes                                                              3950 (31.2)            3129 (8.2)         4117 (3.2)              \<0.001
   Hypothyroidism                                                        799 (6.3)              2080 (5.5)         4488 (3.5)              \<0.001
   Renal failure                                                         157 (1.2)              131 (0.3)          280 (0.2)               \<0.001
   Depression                                                            2775 (21.9)            5542 (14.6)        12 650 (10.0)           \<0.001
   Osteoporosis                                                          65 (0.5)               485 (1.3)          1819 (1.4)              \<0.001

\*For difference between groups, using χ^2^ test for age and sex and univariate conditional multinomial regression for other characteristics.

†Based on six socioeconomic indicators: education level, employment rate, average income of population, living status (alone or not), marital status, and proportion of single parent families in population.

‡In previous five years.

§Includes heart failure, cardiac arrhythmias, valvular disease, pulmonary circulation disorders, and peripheral vascular disorders.

Comparison of overall fracture risk between groups by period
------------------------------------------------------------

Before surgery, 1326 (10.5%) patients in the bariatric group had at least one fracture compared with 3065 (8.1%) obese and 8329 (6.6%) non-obese controls (table 2[](#tbl2){ref-type="table"}). After adjustment, risk of fracture was significantly higher in the bariatric (relative risk 1.30, 95% confidence interval 1.21 to 1.39) and obese groups (1.18, 1.13 to 1.23), compared with the non-obese group. After a mean follow-up of 4.4 (range \<1-13) years, bariatric patients were more likely to have sustained at least one fracture (n=514; 4.1%) compared with the obese (n=1013; 2.7%) and the non-obese (n=3008; 2.4%) groups, with a median time to first fracture of 3.9 (interquartile range 1.6-5.8) years. Postoperative adjusted fracture risk was significantly higher in the bariatric group compared with the non-obese group (relative risk 1.44, 1.29 to 1.59). Fracture risk was also significantly higher in the bariatric group than in the obese group (relative risk 1.38, 1.23 to 1.55; data not shown in tables). Fracture risk over time remained relatively stable for both control groups whereas it increased as early as year one postoperatively in the bariatric group, reaching a first peak at year three and then plateauing, and started to rise again at year eight, reaching a second higher peak at year 11 (fig 1[](#f1){ref-type="fig"}). The number of patients decreased over time in the bariatric group, with 2119 remaining at year 8 and 518 at year 11.

###### 

Relative risks of fracture between groups by period

  Groups                        Period before surgery (or index date)                         Period after surgery (or index date)                                         
  ----------------------------- --------------------------------------- --------------------- -------------------------------------- -- ------------ --------------------- ---------------------
  Bariatric group (n=12 676)    1326 (10.5)                             1.65 (1.55 to 1.76)   1.30 (1.21 to 1.39)                       514 (4.1)    1.85 (1.68 to 2.04)   1.44 (1.29 to 1.59)
  Obese group (n=38 028)        3065 (8.1)                              1.22 (1.17 to 1.27)   1.18 (1.13 to 1.23)                       1013 (2.7)   1.13 (1.04 to 1.21)   1.04 (0.96 to 1.12)
  Non-obese group (n=126 760)   8329 (6.6)                              Reference             Reference                                 3008 (2.4)   Reference             Reference
  P value†                      \-\-\--                                 \<0.001               \<0.001                                   \-\-\--      \<0.001               \<0.001

RR=relative risk.

\*Adjusted for duration of follow-up, material and social deprivation, area of residence, history of fractures (analysis for period after index date only), and number of comorbidities in previous five years, using multivariate conditional Poisson regression model.

†Type III P value for group variable.

![**Fig 1** Hazard function representing non-adjusted fracture risk over time for each group](gagc031922.f1_default){#f1}

Comparison of fracture risk between groups by site and period
-------------------------------------------------------------

Table 3[](#tbl3){ref-type="table"} shows the distribution of fracture sites by group before and after surgery. Before surgery, the proportion of distal lower limb fractures was higher and the proportion of upper limb fractures was lower with the level of obesity. The proportion of clinical spine, hip, femur, and pelvic fractures was similar between groups. After surgery, the proportion of distal lower limb fracture almost halved in the bariatric group (from 64.2% to 37.5%). On the other hand, the proportion of upper limb fracture increased (from 28.3% to 46.1%), and the proportion of pelvic, hip, and femur fracture tripled (from 4.5% to 12.2%), being higher than in the obese (7.2%) and the non-obese (7.3%) groups.

###### 

Distribution of fracture sites between groups by period. Values are numbers (percentages)

  Fracture sites                                              Period before surgery (or index date)                 Period after surgery (or index date)                                
  ----------------------------------------------------------- --------------------------------------- ------------- -------------------------------------- -- ------------ ------------ -------------
  All fractures                                               1639                                    3630          9760                                      621          1145         3375
  Distal lower limb (knee, foot, ankle, and tibia/fibula)     1053 (64.2)                             2149 (59.2)   4800 (49.2)                               233 (37.5)   625 (54.6)   1585 (47.0)
  Clinical spine                                              49 (3.0)                                107 (2.9)     367 (3.8)                                 26 (4.2)     39 (3.4)     124 (3.7)
  Pelvis, hip, and femur                                      73 (4.5)                                151 (4.2)     426 (4.4)                                 76 (12.2)    83 (7.2)     247 (7.3)
  Upper limb (shoulder, humerus, elbow, forearm, and wrist)   464 (28.3)                              1223 (33.7)   4167 (42.7)                               286 (46.1)   398 (34.8)   1419 (42.0)

Table 4[](#tbl4){ref-type="table"} shows relative risks of fracture between groups by fracture site and period. Before surgery, the bariatric and obese groups had a significantly higher risk of sustaining a distal lower limb fracture (relative risk 1.71 (1.57 to 1.85) and 1.43 (1.35 to 1.52), respectively), whereas their risk of having an upper limb fracture was lower (0.89 (0.80 to 1.00) and 0.93 (0.87 to 1.00), respectively) than the non-obese group. The risk of clinical spine, pelvic, hip, and femur fractures was similar between groups. After surgery, the risk of sustaining a distal lower limb fracture in the bariatric group was still slightly higher than in the non-obese group, although this was no longer statistically significant (relative risk 1.15, 0.98 to 1.35). The risks of upper limb (relative risk 1.65, 1.42 to 1.91), clinical spine (1.70, 1.06 to 2.73), and pelvic, hip, and femur fractures (1.88, 1.37 to 2.58) were all higher in the bariatric group compared with the non-obese group. Fracture risk in both control groups remained relatively stable for all sites before and after the index date, except for a decrease in distal lower limb fracture in the obese group and an increase in pelvic, hip, and femur fracture in the non-obese group (fig 2[](#f2){ref-type="fig"}). In the bariatric group, the adjusted risk of having a distal lower limb fracture decreased (relative risk 0.66, 0.56 to 0.78), whereas the risk of upper limb and clinical spine fracture almost doubled and the risk of pelvic, hip, or femur fractures increased 2.5-fold after surgery (fig 2[](#f2){ref-type="fig"}). Figure 3[](#f3){ref-type="fig"} shows non-adjusted fracture-free survival rates by fracture site for each group.

###### 

Relative risks of fracture between groups by fracture site and period

  Groups                                                          Period before surgery (or index date)                         Period after surgery (or index date)                         
  --------------------------------------------------------------- --------------------------------------- --------------------- -------------------------------------- --------------------- ---------------------
  **Distal lower limb (knee, foot, ankle, and tibia/fibula)**                                                                                                                                
  Bariatric group (n=12 676)                                      2.15 (1.99 to 2.32)                     1.71 (1.57 to 1.85)                                          1.47 (1.26 to 1.72)   1.15 (0.98 to 1.35)
  Obese group (n=38 028)                                          1.46 (1.38 to 1.55)                     1.43 (1.35 to 1.52)                                          1.30 (1.18 to 1.44)   1.21 (1.09 to 1.34)
  Non-obese group (n=126 760)                                     Reference                               Reference                                                    Reference             Reference
  P value†                                                        \<0.001                                 \<0.001                                                      \<0.001               0.001
  **Clinical spine**                                                                                                                                                                         
  Bariatric group (n=12 676)                                      1.33 (0.97 to 1.82)                     0.81 (0.58 to 1.13)                                          2.14 (1.40 to 3.28)   1.70 (1.06 to 2.73)
  Obese group (n=38 028)                                          0.96 (0.77 to 1.20)                     0.88 (0.70 to 1.11)                                          1.03 (0.70 to 1.52)   1.00 (0.68 to 1.49)
  Non-obese group (n=126 760)                                     Reference                               Reference                                                    Reference             Reference
  P value†                                                        0.25                                    0.31                                                         0.03                  0.15
  **Pelvis, hip, and femur**                                                                                                                                                                 
  Bariatric group (n=12 676)                                      1.76 (1.30 to 2.38)                     1.08 (0.78 to 1.49)                                          3.12 (2.35 to 4.14)   1.88 (1.37 to 2.58)
  Obese group (n=38 028)                                          1.16 (0.94 to 1.44)                     1.05 (0.84 to 1.31)                                          1.11 (0.84 to 1.47)   0.90 (0.67 to 1.21)
  Non-obese group (n=126 760)                                     Reference                               Reference                                                    Reference             Reference
  P value†                                                        0.009                                   0.84                                                         \<0.001               0.001
  **Upper limb (shoulder, humerus, elbow, forearm, and wrist)**                                                                                                                              
  Bariatric group (n=12 676)                                      1.11 (1.00 to 1.23)                     0.89 (0.80 to 1.00)                                          2.03 (1.77 to 2.34)   1.65 (1.42 to 1.91)
  Obese group (n=38 028)                                          0.96 (0.90 to 1.03)                     0.93 (0.87 to 1.00)                                          0.95 (0.84 to 1.08)   0.90 (0.80 to 1.02)
  Non-obese group (n=126 760)                                     Reference                               Reference                                                    Reference             Reference
  P value†                                                        0.07                                    0.04                                                         \<0.001               \<0.001

RR=relative risk.

\*Adjusted for duration of follow-up, material and social deprivation, area of residence, history of fracture (period after index date only), and number of comorbidities in previous five years, using multivariate conditional Poisson regression model.

†Type III P value for group variable.

![**Fig 2** Change in fracture risk after versus before surgery (or index date) within each group for all fractures and by fracture site. Data are presented as relative risk (95% CI) adjusted for duration of follow-up, age in middle of period, material and social deprivation, area of residence, history of fracture, and number of comorbidities in previous five years, using multivariate Poisson regression model for clustered data](gagc031922.f2_default){#f2}

![**Fig 3** Non-adjusted fracture-free survival rate by site and by group](gagc031922.f3_default){#f3}

Comparison of fracture risk by type of bariatric procedure
----------------------------------------------------------

Between 2006 and 2014, 9300 bariatric surgeries were performed. During this period, the annual number of surgeries increased greatly from 259 in 2006 to 1945 in 2013, and a change in practice occurred. In 2006 mixed restrictive and malabsorptive procedures (Roux-en-Y gastric bypass and biliopancreatic diversion) represented about two thirds of the surgeries, and the other third was adjustable gastric banding. In 2013 restrictive procedures (sleeve gastrectomy and adjustable gastric banding) represented the great majority of surgeries (80%), and biliopancreatic diversion and Roux-en-Y gastric bypass were performed less frequently (10% each). This change is explained by the arrival of sleeve gastrectomy in 2009; since then, it has gained in popularity and represented half of the surgeries in 2013. The proportion of adjustable gastric banding increased initially from 37.5% in 2006 to 50.2% in 2009 and then decreased to 28.1% in 2013. The proportion of biliopancreatic diversion decreased from 46.3% in 2006 to 10.9% in 2013, whereas the proportion of Roux-en-Y gastric bypass remained relatively stable between 6% and 16%.

Appendix 2 gives characteristics of patients undergoing the different types of bariatric surgeries. Patients undergoing sleeve gastrectomy were older and were more likely to be men, to be materially disadvantaged, and to have comorbidities including cardiovascular disease and renal failure. Patients undergoing Roux-en-Y gastric bypass were more likely to be socially disadvantaged and to have comorbidities but less likely to have a history of fracture. Patients undergoing biliopancreatic diversion were less likely to come from metropolitan area and to have a history of fracture or depression. Before surgery, adjusted fracture risks in the surgery groups were all significantly higher than in the non-obese group, except for Roux-en-Y gastric bypass (table 5[](#tbl5){ref-type="table"}). After surgery, only biliopancreatic diversion was clearly associated with an increased risk of fracture (adjusted relative risk 1.60, 1.25 to 2.03). Figure 4[](#f4){ref-type="fig"} shows fracture-free survival rates by type of bariatric surgery.

###### 

Relative risks of fracture by type of bariatric procedure (for period between 2006 and 2014)

  Groups                                Period before surgery (or index date)                         Period after surgery (or index date)                                                                         
  ------------------------------------- --------------------------------------- --------------------- -------------------------------------- --------- -- ------------ --------------------- --------------------- ---------
  Adjustable gastric banding (n=3887)   467 (12.0)                              1.83 (1.65 to 2.04)   1.50 (1.34 to 1.68)                    \<0.001      80 (2.1)     1.43 (1.10 to 1.86)   1.08 (0.83 to 1.39)   0.58
  Sleeve gastrectomy (n=2554)           310 (12.1)                              1.50 (1.32 to 1.71)   1.16 (1.01 to 1.33)                    0.04         35 (1.4)     1.76 (1.17 to 2.64)   1.27 (0.86 to 1.88)   0.23
  Roux-en-Y gastric bypass (n=873)      99 (11.3)                               1.64 (1.32 to 2.04)   1.17 (0.91 to 1.51)                    0.23         23 (2.6)     1.54 (0.96 to 2.46)   1.13 (0.67 to 1.92)   0.65
  Biliopancreatic diversion (n=1986)    212 (10.7)                              1.61 (1.38 to 1.88)   1.20 (1.01 to 1.42)                    0.04         94 (4.7)     2.26 (1.81 to 2.83)   1.60 (1.25 to 2.03)   \<0.001
  Obese group (n=27 900)                2463 (8.8)                              1.20 (1.14 to 1.26)   1.18 (1.12 to 1.24)                    \<0.001      514 (1.8)    1.21 (1.09 to 1.34)   1.12 (1.00 to 1.25)   0.004
  Non-obese group (n=93 000)            6798 (7.3)                              Reference             Reference                                           1422 (1.5)   Reference             Reference             

RR=relative risk.

\*Adjusted for duration of follow-up, material and social deprivation, area of residence, history of fracture (period after index date only), and number of comorbidities in previous five years, using multivariate conditional Poisson regression model.

![**Fig 4** Non-adjusted fracture-free survival rate (all fractures) by group and by type of bariatric procedure (for period between 2006 and 2014). Although fracture-free survival rate appears similar in adjustable gastric banding group to non-obese and obese groups, it is decreasing more rapidly in biliopancreatic diversion and Roux-en-Y gastric bypass groups. Follow-up time for sleeve gastrectomy is too short to draw conclusions](gagc031922.f4_default){#f4}

Discussion
==========

In this large study representative of patients undergoing bariatric surgery in Quebec, mainly women in their early 40s, we showed that severely obese people undergoing surgery are at increased risk of fracture compared with obese and non-obese controls and that their risk remains higher after surgery. Our study highlighted for the first time that risk of fracture is site specific and changes from a pattern associated with obesity (higher susceptibility for distal lower limb fracture and lower susceptibility for upper limb fracture) to a pattern in which risk of lower limb fracture is reduced but risk of fracture at sites typical of osteoporosis is increased (upper limb, clinical spine, pelvis, hip, femur).[@ref28] Furthermore, only biliopancreatic diversion, a mixed malabsorptive and restrictive procedure, was clearly associated with an increased risk of fracture. However, fracture risk associated with sleeve gastrectomy and Roux-en-Y gastric bypass remains inconclusive owing to the small number of cases for Roux-en-Y gastric bypass (n=873; median follow-up of 2.7 years) and the short follow-up for sleeve gastrectomy (median follow-up of 1.3 years).

Comparison with other studies
-----------------------------

To our knowledge, only three studies have examined risk of fracture after bariatric surgery. In a retrospective review of medical files from a single Minnesota hospital including 258 Caucasian patients (82% women; mean age 43.6 years), Nakamura et al showed that fracture risk doubled after Roux-en-Y gastric bypass compared with age and sex matched people from the general US population, after adjustment for physical activity, malnutrition, smoking, alcohol consumption, and fracture history, but not for body mass index.[@ref9] The results of this study are difficult to compare with ours, as Roux-en-Y gastric bypass was underrepresented in our study, precluding us from drawing firm conclusions on fracture risk associated with this procedure. Nevertheless, our study showed that another mixed malabsorptive and restrictive procedure, biliopancreatic diversion, was associated with an increased risk of fracture. The first fracture occurred much earlier in our study (mean of 3.9 *v* 13 years). This may be due to a higher baseline fracture risk in our population, a shorter follow-up, different surgery types, or postoperative management protocols. Lu et al showed that fracture risk was 1.2 times higher after bariatric surgery in 2064 Thai patients (64% women; mean age 31.8 years) compared with 5027 propensity score matched controls followed for a mean of 4.8 years.[@ref11] A higher risk of fracture was restricted to malabsorptive procedures (high gastric bypass and gastroenterostomy), which is in line with our findings. On the other hand, Lalmohamed et al compared fracture risk between 2079 patients (84% women; mean age 44.6 years) undergoing adjustable gastric banding (60%) and Roux-en-Y gastric bypass (29%) and 10 442 controls matched for age, sex, and body mass index.[@ref10] No change in fracture risk following surgery was seen after a mean follow-up of 2.2 years, but there was a trend for an increased risk after three to five years, after adjustment for smoking, falls, fractures, chronic diseases, and drugs. The short follow-up, the small number of fractures (n=39), and the use of mainly adjustable gastric banding, which, according to our findings, does not seem to have a negative effect on bone metabolism and is less likely to be performed in severely obese patients who have several comorbidities, may explain the negative findings. This is, however, the only study using a control group that was matched for body mass index.

Our study showed that a positive relation existed between the level of obesity and risk of fracture. At baseline, fracture risk was about 30% higher in the group undergoing bariatric surgery and 18% greater in the obese group compared with the non-obese group. The degree of obesity is probably the main explanation for the difference in fracture risk observed between the obese group and the group undergoing bariatric surgery, as our groups were not matched for body mass index or for comorbidities.[@ref29] The typical body mass index in the Quebec bariatric population is around 45-50, which is likely significantly higher than that of the obese control group.[@ref30] [@ref31] [@ref32] Our results support recent data suggesting that obesity may not be as protective for fracture as was originally thought. Johansson et al showed, in a large meta-analysis including 398 610 women, that when adjusted for bone mineral density, higher body mass index was associated with a slight but significant increase in fracture risk (hazard ratio per 1 unit increase in body mass index 1.01, 95% confidence interval 1.01 to 1.02; P\<0.001).[@ref33] These results suggest that the increase in bone mineral density seen with the increase in weight is not sufficient to protect against fractures. Another proposed explanation is that in obesity, bone quality plays a predominant role over bone quantity in decreasing bone strength.[@ref34] Prevalent factors in obesity that may affect bone strength and fracture risk include vitamin D deficiency, secondary hyperparathyroidism, subclinical chronic inflammation, type 2 diabetes, and changes in adipokines.[@ref18] [@ref35] In our study, patients in the bariatric group had more comorbidities than did people in the other groups, including a higher prevalence of type 2 diabetes. However, increased fracture risk in obesity is unlikely to be explained only by the presence of comorbidities, as we adjusted for this factor in our analyses. Our study also showed that fracture risk is site specific in obesity. At baseline, patients in both the bariatric and the obese groups were at a higher risk of a distal lower limb fracture but at a lower risk of an upper limb fracture compared with the non-obese group. The risk of ankle fracture is known to increase linearly with the increase in weight (hazard ratio per 5 kg increase 1.05, 1.02 to 1.07; P\<0.001)[@ref36] and body mass index (relative risk per 5 unit increase 1.18, 1.12 to 1.24; P\<0.001).[@ref37] The increased risk in distal lower limb fracture with obesity is thought to result from the fact that the lower body has to support a greater weight.[@ref35] Regarding the lower risk of upper limb fracture with obesity, our results are difficult to compare with other studies owing to the different grouping of fracture sites. Some studies have shown an increase in risk of proximal humerus and shoulder fracture,[@ref33] [@ref38] whereas others failed to show this.[@ref36] Moreover, some but not all studies showed an increase in risk of distal forearm and wrist fracture with obesity.[@ref33] [@ref36] [@ref38] The lower risk of upper limb fracture observed in our study may be due to a different falls pattern in obese compared with non-obese people.[@ref35] [@ref38] Contrary to what was observed in several studies,[@ref33] [@ref37] [@ref38] risk of hip and femur fracture was similar between obese and non-obese people in our study, likely owing to the small number of such fractures in our relatively young population. Further studies are needed to elucidate the mechanisms explaining the site specific fracture risk in obese people.

Our study also showed for the first time that bariatric surgery seems to have deleterious effects on bone at some sites but limited effects at other sites. Whereas risk of distal lower limb fracture was reduced after surgery, the risk of upper limb, clinical spine, hip, femur, and pelvic fracture increased. The specific factors explaining the changes in fracture sites after bariatric surgery remain largely hypothetical and incompletely understood. For instance, the reduction in distal lower limb fractures after surgery may be driven by the lower weight supported by this part of the body after weight loss. However, whereas weight reduction seemed to be beneficial on the risk of distal lower limb fracture, this effect was not seen in other weight bearing sites such as the hip and pelvis, suggesting that other factors are involved. The increase in upper limb fractures may be partly explained by secondary hyperparathyroidism, which is prevalent after malabsorptive surgeries and known to affect predominantly cortical bone.[@ref18] [@ref38] [@ref39] [@ref40] However, the fact that fracture risk at the lower limb, which is also mainly composed of cortical bone, was not increased in our study suggests that other factors play a role in the increase in risk of upper limb fracture after bariatric surgery. One hypothesis is that falls pattern changes after bariatric surgery, resulting in different fracture sites. Although no study has evaluated falls pattern in this context, prevalence of falls is high after surgery; 34% of patients reported two or more falls and 24% reported balance problems five years after Roux-en-Y gastric bypass.[@ref41] Moreover, a recent randomized controlled trial comparing conventional treatment and Roux-en-Y gastric bypass for diabetes found a greater number of falls leading to fractures in the surgery group than in the conventional group after two years.[@ref42] These results may be explained by the fact that rapid weight loss often results in loss of muscle,[@ref43] which could predispose to falls.[@ref44] Finally, the change to an osteoporotic-like fracture pattern after surgery may be partly explained by the ageing of our mainly female population through follow-up, some becoming menopausal. This factor could be involved in the second peak in fracture risk observed in our study at year 11 after surgery, as the mean age of our cohort was 42 years at study entry. This second peak may also be artifactual owing to smaller sample size at this time point (n=518). However, menopause is unlikely to explain the first peak in fracture risk that occurred three years after surgery.

The increase in fracture risk at sites typically seen in osteoporosis is consistent with studies showing that bone loss occurs at most osteoporotic sites after bariatric surgery---namely, the forearm, hip, femoral neck, and spine.[@ref23] [@ref45] Also, markers of bone turnover, and particularly of bone resorption, increase markedly and rapidly after bariatric surgery.[@ref3] [@ref39] These markers stay elevated in the long term, up to 10 years after biliopancreatic diversion in one study,[@ref8] even when weight has stabilized. This increase is also seen despite adequate calcium and vitamin D supplementation and normal parathyroid hormone concentrations.[@ref2] [@ref46] Altogether, these results imply that other factors are involved and that the increase in bone remodeling seen after bariatric surgery is likely to be multifactorial. Several mechanisms have been proposed, but their relative importance remains unclear and likely depends on the type of bariatric procedure. Nutritional factors are probably involved, as well as factors associated with weight loss and with anatomical changes induced by surgery. One recent study showed that sclerostin concentrations, which are increased after surgery owing to mechanical unloading, correlate with the increase in bone loss at the lumbar spine, total hip, and total body.[@ref16] The effect on bone of changes in hormonal factors associated with weight loss, such as the diminution of leptin and estrogen concentrations and the increase in adiponectin concentrations, is complex and remains to be clarified in humans, especially after bariatric surgery. Reduced peripheral leptin and estrogen concentrations could lead to an increase in bone resorption.[@ref18] [@ref39] [@ref47] On the other hand, although adiponectin decreased osteoclastogenesis and promoted osteoblastogenesis in vivo and in vitro, clinical studies showed an inverse association between adiponectin concentrations and bone mineral density.[@ref2] [@ref17] [@ref18] Similarly, the roles of ghrelin, a hormone secreted by the stomach that promotes osteoblast function and bone formation, and gut hormones such as glucagon-like peptide 1 and peptide YY in the alteration of bone metabolism after surgery are unknown.[@ref3] [@ref18] Other factors such as metabolic acidosis could also be implicated in the bone loss seen after bariatric surgery by increasing urinary calcium and by activating osteoclast activity.[@ref48] [@ref49] Finally, physical activity may be increased after surgery, possibly leading to more traumatic fractures.

Regarding the effect of different types of bariatric surgery on fracture risk, the results of published studies are in line with our findings. We found that biliopancreatic diversion, a mixed malabsorptive and restrictive procedure, was associated with an increased risk of fracture and that adjustable gastric banding was not.[@ref9] [@ref10] [@ref11] It seems plausible that surgeries that include a malabsorptive component lead to greater bone loss than do purely restrictive procedures, as they induce greater weight loss and are more likely to cause deficiencies in nutrients that are important for bone health, including calcium, vitamin D, and protein.[@ref23] [@ref29] [@ref50] After all bariatric surgeries, especially mixed malabsorptive and restrictive procedures, clinical guidelines recommend supplementation with multivitamins, calcium, and vitamin D, ensuring adequate protein intake, and encouraging aerobic physical activity and strength training.[@ref51] However, the efficacy of these interventions relies on long term adherence, which at least for multivitamin use was reported to be poor in both adolescents and adults (30% and 50%, respectively).[@ref52] [@ref53] Moreover, a recent survey showed that healthcare professionals who take care of bariatric patients often do not follow recommendations on multivitamin, calcium, and vitamin D supplementation.[@ref54] Unfortunately, we could not assess compliance with supplement and physical activity recommendations in our study. However, vitamin D deficiency was reported to be very low after biliopancreatic diversion in Quebec,[@ref55] so compliance with vitamin D supplements does not seem to be the main factor explaining our results, at least for this procedure. Nevertheless, our results emphasize the importance of reinforcing adherence of patients and bariatric centers to clinical guidelines. A recently published prospective interventional study showed that a multimodal approach including calcium citrate, vitamin D, and protein supplements, combined with Nordic walking (45 minutes three times a week) and strength perseverance and equipment training (30 minutes twice a week) for two years resulted in a lower decrease in lean body mass as well as in bone mineral density at the lumbar spine, hip, and femoral neck and a lower increase in bone turnover markers and parathyroid hormone in patients undergoing Roux-en-Y gastric bypass and sleeve gastrectomy.[@ref46] Although no evidence yet shows that this approach reduces fracture risk, it certainly contributes to limiting postoperative muscle and bone loss. Good quality randomized controlled trials are needed to delineate the best strategy to adopt to minimize the effect of bariatric surgery on bone. In addition, as long term benefits of bariatric surgery on reduction of comorbidities and mortality, improved quality of life, and reduced healthcare costs have been well demonstrated over the past 20 years,[@ref56] [@ref57] [@ref58] and as randomized controlled trials have confirmed the superiority of bariatric surgery over medical treatment,[@ref59] [@ref60] [@ref61] the risk of bone fracture after surgery must be balanced against these well described long term health benefits.

Strengths and limitations of study
----------------------------------

Our study has several strengths. Firstly, this is one of the very few studies that have assessed the hard outcome of fracture after bariatric surgery and, most importantly, our sample size is by far the largest to date, enabling us to assess fracture risk by site. We are also confident that fractures and study groups were correctly identified, as we used a validated algorithm for fracture identification, intervention codes for bariatric surgery were repeated in both the PCD and Med-Echo, and stringent criteria were established to identify obese people. Furthermore, the use of healthcare administrative databases to identify obese people has been shown to have a good positive predictive value.[@ref62]

The study does, however, have limitations. The bariatric and the obese groups were not matched for body mass index, as this information was not available in the databases. This could have resulted in the group of obese controls being less obese and having fewer comorbidities than the bariatric group, which could partly explain the difference in fracture risk observed between these groups at baseline and follow-up. However, the fact that fracture sites changed after bariatric surgery suggests that the increased baseline fracture risk in the bariatric group is not the sole factor explaining the higher risk of fracture after bariatric surgery. Although we acknowledge that the impossibility of assessing body mass index in each group is an important limitation of our study, we think that both comparator groups are still valuable as they provide a gradient of obesity across the groups. In an attempt to bypass this limitation, we also compared each group with itself after versus before the index date. In addition, surgical subgroups were not necessarily comparable in terms of body mass index and comorbidities, which could partly explain differences in fracture risk among bariatric procedures. Moreover, we did not exclude patients with a history of fracture who could have had an underlying secondary cause of osteoporosis before surgery. We decided to include all patients undergoing bariatric surgery to ensure that this population was representative of the bariatric population. Previous fracture history or risk factors for osteoporosis are not contraindications for surgery, and previous history of fracture is a strong risk factor for future fracture. As such, excluding patients with a previous fracture history would exclude patients who are at high risk of fracture after bariatric surgery. In addition, only clinical spine fractures were identified in the databases, leading to an underestimation of fractures at this site. Another limitation is that the level of trauma and several important confounders that may affect bone health or risk of fracture or falls were not assessed, including drugs, physical activity, weight loss, smoking, and alcohol use. Finally, as reliable codification of bariatric procedures in Med-Echo and the PCD was not available until 2006, the follow-up for sleeve gastrectomy was short and the number of Roux-en-Y gastric bypasses was small, precluding us from drawing firm conclusions on fracture risk with these procedures. Also, the great majority of our study population had a Europid background, and results of this study may not be generalizable to other ethnic groups.

Conclusions and policy implications
-----------------------------------

In conclusion, severely obese patients undergoing bariatric surgery are more susceptible to fracture than are obese and non-obese people, and this risk remains higher after surgery. Moreover, fracture risk is site specific in this group before and after surgery. Bariatric surgery seems to have a limited effect on risk of lower limb fracture, but it seems to increase susceptibility for fracture sites typically seen in osteoporosis. Although our study suggests that biliopancreatic diversion is associated with an increased fracture risk and adjustable gastric banding is not, we could not make conclusions about fracture risk associated with sleeve gastrectomy and Roux-en-Y gastric bypass owing to short follow-up and small number of patients. To minimize the effect of bariatric surgery on bone, guidelines should be followed and the importance of adherence to supplements and physical activity should be reinforced among patients and healthcare professionals. A referral to a bone specialist should be considered in cases in which fracture risk is high before surgery or when the biochemical parameters do not normalize or a fracture occurs after surgery. Finally, it is important to weigh the benefits and risks of surgery for a given patient in order to propose the type of surgery that is best suited to the patient, as the efficacy of bariatric surgeries differs in terms of resolution of comorbidities associated with obesity.[@ref61] More studies that aim at understanding the mechanisms underlying the increased risk of fracture and at evaluating the efficacy of preventive and therapeutic strategies to reduce the effect of bariatric surgery on bone are needed given the paucity of evidence based guidelines in this area.

### What is already known on this topic

1.  Bariatric surgery leads to an increase in bone turnover markers and a decrease in bone mineral density

2.  Whether these abnormalities in bone metabolism translate into an increase in fracture risk remains uncertain, as the three studies assessing the effect of bariatric surgery on fracture reported contradicting results

3.  Moreover, all previous studies were underpowered to properly assess fracture sites

### What this study adds

1.  Severely obese patients undergoing bariatric surgery are at increased risk of fracture before surgery compared with obese and non-obese controls, and this risk remains higher after surgery

2.  Fracture risk is site specific and changes from a pattern associated with obesity to a pattern typical of osteoporosis after surgery

3.  Fracture risk assessment and management should be part of bariatric care
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